• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 03/02/15

    • 30-Day SEC Yield1

      -0.11%
    • Total Net Assets

      $741.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/18/2015
  • Portfolio Composition (%)
    as of 03/02/15

    • % of Net Assets
    • Stocks

      100.00
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.00
  • Download All HoldingsAll Holdings (%) as of 03/02/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    942,576
    97,867,66613.21
    Amgen Inc
    AMGN US
    523,461
    83,560,07911.28
    Celgene Corp
    CELG US
    636,419
    76,567,57010.33
    Biogen Idec Inc
    BIIB US
    143,267
    59,568,9868.04
    Biomarin Pharmaceutical Inc
    BMRN US
    337,216
    36,560,9594.93
    Alexion Pharmaceuticals Inc
    ALXN US
    178,887
    33,026,1184.46
    Incyte Corp Ltd
    INCY US
    369,852
    32,798,4754.43
    Illumina Inc
    ILMN US
    167,636
    32,531,4424.39
    Pharmacyclics Inc
    PCYC US
    146,291
    32,372,7354.37
    Vertex Pharmaceuticals Inc
    VRTX US
    262,983
    31,602,6674.26
    Regeneron Pharmaceuticals Inc
    REGN US
    72,876
    30,494,2334.11
    Medivation Inc
    MDVN US
    215,691
    26,109,3963.52
    United Therapeutics Corp
    UTHR US
    144,011
    22,382,1903.02
    Alnylam Pharmaceuticals Inc
    ALNY US
    201,663
    21,255,2802.87
    Qiagen Nv
    QGEN US
    821,515
    20,546,0902.77
    Isis Pharmaceuticals Inc
    ISIS US
    263,611
    17,609,2152.38
    Alkermes Plc
    ALKS US
    246,258
    17,600,0592.37
    Grifols Sa
    GRFS US
    429,240
    13,654,1241.84
    Puma Biotechnology Inc
    PBYI US
    59,655
    12,751,2561.72
    Charles River Laboratories Internationa
    CRL US
    132,354
    10,158,1701.37
    Cepheid Inc
    CPHD US
    157,266
    9,008,1961.22
    Mannkind Corp
    MNKD US
    1,058,968
    7,031,5480.95
    Intercept Pharmaceuticals Inc
    ICPT US
    30,575
    6,895,8860.93
    Myriad Genetics Inc
    MYGN US
    138,272
    4,630,7290.62
    Seattle Genetics Inc
    SGEN US
    125,182
    4,506,5520.61
    Other/Cash
    -33,3220.00
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.